Skip to main content
. 2014 Apr 28;16(11):1530–1540. doi: 10.1093/neuonc/nou060

Table 2.

Distribution of patients according to hospitalization burden after index hospitalization*

Characteristic <25% of Remaining Life Spent Hospitalized (n = 3906) 25%–100% of Remaining Life Spent Hospitalized (n = 991) P
Age at diagnosis, y <.001
 64 to ≤74 54.1 43.5
 75 to ≤84 38.4 48.1
 85+ 7.6 8.4
Gender .967
 Male 51.5 51.5
 Female 48.5 48.5
Race/ethnicity .005
 White, non-Hispanic 88.9 85.8
 Hispanic 5.5 6.2
 Black 3.2 5.9
 Asian 1.5 1.1
 Other 0.9 1
Marital status .002
 Married 61.6 56.6
 Unmarried 12.1 12.7
 Unknown 26.3 30.7
Comorbidity score <.001
 0 63.5 52.6
 1 25.2 27.1
 2+ 11.4 20.3
Year of diagnosis .816
 1999–2001 27.4 27.1
 2002–2004 36.5 36.4
 2005–2007 36.1 36.4
Census tract income .856
 Lower income (<median) 34.2 35.5
 Higher income (>median) 65.8 64.5
SEER registry region .06
 Northeast 7.3 6.4
 South 10.7 8.9
 Midwest 15.5 18.4
 West 66.5 66.4
Tumor extent .046
 1 brain lobe 75.4 71.9
 2+ brain lobes 18 21.3
 Unknown 6.6 6.9
Surgery <.001
 Extensive (GTR) 27.4 19.4
 Limited (biopsy/STR) 72.6 80.6
Radiotherapy delivered <.001
 Yes 77.9 57.8
 No 22.1 42.2
Temozolomide delivered <.001
 Yes 21.2 5.5
 No 78.8 94.5
Other chemotherapy delivered <.001
 Yes 23.3 10.5
 No 76.7 89.5
Discharged home after index hospitalization <.001
 Yes 52.4 25.7
 No 47.6 74.3
Cumulative days hospitalized after index hospitalization, ** median (IQR) 13 (7–22) 26 (17–41) <.001

Abbreviations: GTR, gross total resection; STR, subtotal resection; IQR, interquartile range.

*Excluding the 132 patients who did not survive their initial hospitalization for glioblastoma diagnosis. All values represent percentages.

**Among all patients surviving index hospitalization.